States

Latest KFF Health News Stories

Lacking Votes, Calif. Assembly Shelves Aid-In-Dying Bill

KFF Health News Original

Supporters said they will continue to work with Assembly members to build support for the bill, which would allow doctors to write lethal prescriptions for some terminally ill patients with less than six months to live.

Disability Advocates Fight Assisted Suicide Measures

KFF Health News Original

Disability rights advocates are speaking up in opposition to a bill currently being considered by California legislators that would allow terminally ill patients to get prescriptions to end their lives. Their opposition stems from worries that if it becomes law, depression and incorrect prognoses may lead people with serious disabilities to end their lives prematurely.

Having Survived Court Ruling, Insurance Markets Still Face Economic Threats

KFF Health News Original

Among the challenges for these online exchanges set up by the health law are attracting more customers, keeping consumers’ health costs affordable and quality high, and finding enough financing.

Not Expanding Medicaid Can Cost Local Taxpayers

KFF Health News Original

Property owners in Dallas County, Texas, paid more than $467 million in taxes last year to Parkland Health and Hospital System, the county’s only public hospital, to provide medical care to the poor and uninsured. If Texas had expanded Medicaid, that amount would have been lower.

California Caps What Patients Pay For Pricey Drugs. Will Other States Follow?

KFF Health News Original

Beginning in 2016, most Covered California customers will not have to pay more than $150 or $250 per prescription, per month. The price caps are a response to very expensive new drugs used to treat hepatitis and other serious illnesses.

Looming Decision Could Cripple Part Of N.C. Health Insurance Market

KFF Health News Original

If the Supreme Court invalidates some Obamacare tax subsidies, individual health insurance marketplaces in places like North Carolina could be hurt by the remaining deluge of sick people who keep coverage — and the higher insurance premiums their presence demands.

Prescription Drug Price Battles Show No Sign Of Letting Up

KFF Health News Original

A pair of new cholesterol drugs is renewing a battle between pharmaceutical companies, which charge huge sums of money for new blockbuster drugs, and payers for those treatments, which include insurers, Medicare and Medicaid.